Literature DB >> 24526506

Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.

Peter Mitro1, Pavol Murin, Gabriel Valocik, Milos Simurda.   

Abstract

BACKGROUND: Overall response rate to cardiac resynchronization therapy (CRT) is still not optimal. The aim of the study was to evaluate the influence of the regional myocardial contractile reserve during dobutamine infusion in the area of left ventricular (LV) electrode on the response rate and reverse remodeling LV in patients receiving CRT.
METHODS: Biventricular pacemaker was implanted in 41 consecutive patients (33 men, mean age 62 ± 10 years) with LV ejection fraction (LVEF) ≤ 35%, New York Heart Association class III and QRS duration ≥ 120 ms. Myocardial contractile reserve was assessed by LV strain during dobutamine infusion (20 μg/kg/min) using speckle tracking echocardiography. Patients were classified as responders if an increase in LVEF ≥ 5% or decrease in end-systolic volume ≥ 15% was observed after 6 months of CRT.
RESULTS: Twenty-four patients were responders and 17 were non-responders. During dobutamine infusion at a rate of 20 μg/kg/min, responders showed significant increase in regional deformation (Δ strain) when compared to non-responders (2.14 ± 2.9 vs. - 0.94 ± 1.74, p = 0.042). Patients with increased deformation in the LV lead area during dobutamine stimulation were more likely to be responders to CRT compared to patients without increased deformation in this area (81% vs. 20%, p = 0.0002). They exhibited significant increase in LVEF (8.8% ± 10.3% vs. 0.3% ± 6.4%, p = 0.01). LV electrode localization in viable myocardium was a good predictor of response to CRT (AUC 0.852, p < 0.0001).
CONCLUSIONS: Regional contractile reserve assessed by strain rate echocardiography during dobutamine infusion predicts the response to CRT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24526506     DOI: 10.5603/CJ.a2014.0003

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.

Authors:  Neal A Chatterjee; Jagmeet P Singh; Jackie Szymonifka; Roderick C Deaño; Wai-Ee Thai; Bryan Wai; James K Min; James L Januzzi; Quynh A Truong
Journal:  Int J Cardiol       Date:  2015-12-11       Impact factor: 4.164

Review 2.  The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.

Authors:  Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Christos Damaskos; Antonios Athanasiou; Efthimios Livanis; Vassilis Voudris
Journal:  Open Cardiovasc Med J       Date:  2017-12-19

3.  Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Marek Grabka; Magdalena Kocierz-Woźnowska; Maciej Wybraniec; Maciej Turski; Marcin Wita; Krystian Wita; Katarzyna Mizia-Stec
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.